(1->4)-beta-D-glucan multiple interactions ISO RGD:732675 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FGL2 mRNA CTD PMID:36331819 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of FGL2 protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO RGD:732675 6480464 1, 2-Dimethylhydrazine results in decreased expression of FGL2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1347654 6480464 Dinitrochlorobenzene results in decreased expression of FGL2 mRNA CTD PMID:17374397 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FGL2 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1347654 6480464 [Progesterone co-treated with Estradiol] results in increased expression of FGL2 mRNA CTD PMID:17404688 17beta-estradiol increases expression ISO RGD:1347654 6480464 Estradiol results in increased expression of FGL2 mRNA CTD PMID:25878060 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:732675 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347654 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGL2 mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732675 6480464 Tetrachlorodibenzodioxin results in increased expression of FGL2 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732675 6480464 Tetrachlorodibenzodioxin affects the expression of FGL2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FGL2 mRNA CTD PMID:19490992 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1347654 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FGL2 mRNA] CTD PMID:11007951 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FGL2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1347654 6480464 Lactic Acid results in increased expression of FGL2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:732675 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of FGL2 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FGL2 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:732675 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FGL2 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1347654 6480464 Oxazolone results in decreased expression of FGL2 mRNA CTD PMID:17374397 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FGL2 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of FGL2 mRNA CTD PMID:31881176 acetohydrazide decreases expression ISO RGD:732675 6480464 acetylhydrazine results in decreased expression of FGL2 mRNA CTD PMID:15282401 acrolein increases expression ISO RGD:732675 6480464 Acrolein results in increased expression of FGL2 mRNA CTD PMID:18515264 acrylamide increases expression ISO RGD:732675 6480464 Acrylamide results in increased expression of FGL2 mRNA CTD PMID:35032568 aldehydo-D-glucose increases expression ISO RGD:732675 6480464 Glucose results in increased expression of FGL2 mRNA CTD PMID:33448797 aldehydo-D-glucose multiple interactions ISO RGD:732675 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] CTD PMID:33448797 all-trans-retinoic acid increases expression ISO RGD:1347654 6480464 Tretinoin results in increased expression of FGL2 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FGL2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FGL2 mRNA CTD PMID:30779732 arsane increases methylation ISO RGD:1347654 6480464 Arsenic results in increased methylation of FGL2 gene CTD PMID:24525453 arsenic atom increases methylation ISO RGD:1347654 6480464 Arsenic results in increased methylation of FGL2 gene CTD PMID:24525453 arsenous acid decreases expression ISO RGD:1347654 6480464 Arsenic Trioxide results in decreased expression of FGL2 mRNA CTD PMID:19128835 asbestos affects expression ISO RGD:1347654 6480464 Asbestos affects the expression of FGL2 mRNA CTD PMID:17297452 benzo[a]pyrene increases expression ISO RGD:732675 6480464 Benzo(a)pyrene results in increased expression of FGL2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1347654 6480464 Benzo(a)pyrene results in decreased expression of FGL2 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1347654 6480464 Benzo(a)pyrene results in increased methylation of FGL2 exon CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1347654 6480464 7 more ... CTD PMID:20382639 benzoates decreases expression ISO RGD:1347654 6480464 Benzoates analog results in decreased expression of FGL2 mRNA CTD PMID:29472718 bisphenol A increases expression ISO RGD:732675 6480464 bisphenol A results in increased expression of FGL2 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A decreases expression ISO RGD:1347654 6480464 bisphenol A results in decreased expression of FGL2 mRNA CTD PMID:27685785 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGL2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:732675 6480464 bisphenol F results in increased expression of FGL2 mRNA CTD PMID:30951980 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of FGL2 mRNA CTD PMID:19167457 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of FGL2 promoter CTD PMID:22457795 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FGL2 mRNA CTD PMID:25993096 cadmium sulfate multiple interactions ISO RGD:732675 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of FGL2 mRNA] CTD PMID:16221973 carbon nanotube increases expression ISO RGD:732675 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of FGL2 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:1347654 6480464 CGP 52608 promotes the reaction [RORA protein binds to FGL2 gene] CTD PMID:28238834 chromium(6+) affects expression ISO RGD:732675 6480464 chromium hexavalent ion affects the expression of FGL2 mRNA CTD PMID:28472532 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FGL2 mRNA CTD PMID:27523638 cycloheximide multiple interactions ISO RGD:1347654 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FGL2 mRNA] CTD PMID:11007951 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FGL2 mRNA CTD PMID:21865292 D-glucose multiple interactions ISO RGD:732675 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] CTD PMID:33448797 D-glucose increases expression ISO RGD:732675 6480464 Glucose results in increased expression of FGL2 mRNA CTD PMID:33448797 DDT decreases expression EXP 6480464 DDT results in decreased expression of FGL2 mRNA CTD PMID:30207508 diarsenic trioxide decreases expression ISO RGD:1347654 6480464 Arsenic Trioxide results in decreased expression of FGL2 mRNA CTD PMID:19128835 dibenz[a,h]anthracene increases expression ISO RGD:732675 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FGL2 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:732675 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGL2 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FGL2 mRNA CTD PMID:33729688 diuron decreases expression EXP 6480464 Diuron results in decreased expression of FGL2 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of FGL2 mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1347654 6480464 Doxorubicin results in decreased expression of FGL2 mRNA CTD PMID:29803840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of FGL2 mRNA CTD PMID:30307764 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of FGL2 mRNA CTD PMID:18035473 folic acid decreases expression ISO RGD:732675 6480464 Folic Acid results in decreased expression of FGL2 mRNA CTD PMID:25629700 fucoxanthin multiple interactions ISO RGD:732675 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] CTD PMID:33448797 glucose multiple interactions ISO RGD:732675 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] CTD PMID:33448797 glucose increases expression ISO RGD:732675 6480464 Glucose results in increased expression of FGL2 mRNA CTD PMID:33448797 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of FGL2 mRNA CTD PMID:20097248 lipopolysaccharide multiple interactions ISO RGD:1347654 6480464 [S-(1 more ... CTD PMID:35811015 N-nitrosodiethylamine increases expression ISO RGD:732675 6480464 Diethylnitrosamine results in increased expression of FGL2 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FGL2 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:1347654 6480464 N-Nitrosopyrrolidine results in decreased expression of FGL2 mRNA CTD PMID:32234424 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of FGL2 protein CTD PMID:17337753 nickel atom decreases expression ISO RGD:1347654 6480464 Nickel results in decreased expression of FGL2 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1347654 6480464 Nickel results in increased expression of FGL2 mRNA CTD PMID:25583101 nickel sulfate decreases expression ISO RGD:1347654 6480464 nickel sulfate results in decreased expression of FGL2 mRNA CTD PMID:16780908 , PMID:17374397 O-methyleugenol decreases expression ISO RGD:1347654 6480464 methyleugenol results in decreased expression of FGL2 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGL2 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:732675 6480464 Acetaminophen affects the expression of FGL2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1347654 6480464 Acetaminophen results in increased expression of FGL2 mRNA CTD PMID:26690555 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1347654 6480464 perfluorooctane sulfonic acid results in decreased expression of FGL2 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732675 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FGL2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:732675 6480464 Phenobarbital affects the expression of FGL2 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:732675 6480464 pirinixic acid results in increased expression of FGL2 mRNA CTD PMID:17426115 potassium bromate multiple interactions ISO RGD:732675 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA] CTD PMID:27082013 potassium bromate affects expression ISO RGD:732675 6480464 potassium bromate affects the expression of FGL2 mRNA CTD PMID:27082013 progesterone multiple interactions ISO RGD:1347654 6480464 [Progesterone co-treated with Estradiol] results in increased expression of FGL2 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:732675 6480464 Progesterone results in increased expression of FGL2 mRNA CTD PMID:22238285 quercetin decreases expression ISO RGD:1347654 6480464 Quercetin results in decreased expression of FGL2 mRNA CTD PMID:15309432 rac-lactic acid increases expression ISO RGD:1347654 6480464 Lactic Acid results in increased expression of FGL2 mRNA CTD PMID:30851411 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1347654 6480464 [S-(1 more ... CTD PMID:35811015 S-adenosyl-L-methioninate decreases expression ISO RGD:732675 6480464 S-Adenosylmethionine results in decreased expression of FGL2 mRNA CTD PMID:18098314 S-adenosyl-L-methionine decreases expression ISO RGD:732675 6480464 S-Adenosylmethionine results in decreased expression of FGL2 mRNA CTD PMID:18098314 sodium arsenate increases expression ISO RGD:732675 6480464 sodium arsenate results in increased expression of FGL2 mRNA CTD PMID:21795629 sodium fluoride decreases expression ISO RGD:732675 6480464 Sodium Fluoride results in decreased expression of FGL2 mRNA CTD PMID:27862939 Soman increases expression EXP 6480464 Soman results in increased expression of FGL2 mRNA CTD PMID:19281266 sulforaphane increases expression ISO RGD:732675 6480464 sulforaphane results in increased expression of FGL2 mRNA CTD PMID:30529165 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:21865292 tacrolimus hydrate increases expression ISO RGD:732675 6480464 Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:29362864 tetrachloromethane increases expression ISO RGD:732675 6480464 Carbon Tetrachloride results in increased expression of FGL2 mRNA CTD PMID:27339419 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FGL2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:732675 6480464 titanium dioxide results in decreased expression of FGL2 mRNA CTD PMID:23557971 , PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGL2 mRNA CTD PMID:25729387 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of FGL2 mRNA CTD PMID:21683754 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FGL2 mRNA CTD PMID:33387578 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of FGL2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:732675 6480464 triptonide results in increased expression of FGL2 mRNA CTD PMID:33045310 undecane increases expression EXP 6480464 undecane results in increased expression of FGL2 protein CTD PMID:17337753 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FGL2 mRNA CTD PMID:29427782 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of FGL2 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FGL2 mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1347654 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of FGL2 mRNA CTD PMID:20370541 zoledronic acid decreases expression ISO RGD:1347654 6480464 zoledronic acid results in decreased expression of FGL2 mRNA CTD PMID:24714768